Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Health Phys ; 47(3): 417-27, 1984 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6500943

RESUMO

Pregnant rats were housed in 85Kr atmospheres at 10, 15, or 20 days of gestation (dg) and killed after 4 hr of exposure to 37-40 nCi/ml. The 85Kr was present in the components of the fetoplacental unit (FPU) at concentrations (nCi/g) equivalent to approximately 2% of the concentration (nCi/ml) in the exposure atmosphere. Tissue distribution of 85Kr and the distribution of radiation dose did not suggest any unusual hazard to the fetus associated with exposure of pregnant animals. This conclusion was tested using 5-day exposures to a 1000-fold increased concentration: 40 muCi/ml. The main effects observed in pregnant rats exposed to 85Kr from 7-12 or 12-17 dg (estimated radiation dose of 5 X 10(3) rad to maternal lung and 5 X 10(5) rad to maternal skin surface) were deaths, impaired weight gain and skin lesions. Secondarily, the maternal toxicity led to indications of embryotoxicity, although the incidence of malformations was not increased by the estimated 50-rad dose to the FPU.


Assuntos
Feto/efeitos da radiação , Criptônio , Troca Materno-Fetal , Radioisótopos , Anormalidades Induzidas por Radiação , Animais , Peso Corporal/efeitos da radiação , Feminino , Morte Fetal/etiologia , Criptônio/metabolismo , Gravidez , Radioisótopos/metabolismo , Ratos , Ratos Endogâmicos , Distribuição Tecidual
3.
Environ Health Perspect ; 57: 13-23, 1984 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-6499796

RESUMO

The effects of ethylene glycol monoethyl ether (EGEE) were determined on development in utero. Pregnant New Zealand White rabbits were exposed to air or 160 or 617 ppm EGEE for 7 hr/day from 1 to 18 days of gestation (dg). Virgin Wistar rats were exposed to 150 or 649 ppm EGEE or air 5 days/week for the 3 weeks immediately preceding their breeding. Sperm-positive rats were subsequently exposed to air or 202 or 767 ppm EGEE for 7 hr/day from 1 to 19 dg. Group sizes were 29 to 38 per concentration for both species. Pregestational exposure of rats had no effect on mating success, and there was no effect of EGEE exposure on establishment of pregnancy in either species. Rabbits exposed to the both concentrations had decreased food intake and depressed weight gain. Exposure-related mortality occurred in the 617 ppm EGEE group of rabbits. The only toxic sign seen in rats was reduced weight gain after exposure to 767 ppm EGEE. Exposure induced high embryomortality at maternal toxic concentrations in rats and rabbits, while lower levels induced fetal growth retardation in rats but not in rabbits. Gestational exposure increased the incidence of anomalies and variations; these were primarily of soft tissues in rabbits and of skeleton in rats. Thus, significant evidence of terata, fetal growth retardation and embryomortality were induced in rabbits and rats at levels that were below or similar to those that induced maternal manifestation of toxicity. These data implicate EGEE as a teratogen.


Assuntos
Anormalidades Induzidas por Medicamentos/etiologia , Poluentes Ocupacionais do Ar/toxicidade , Etilenoglicóis/toxicidade , Animais , Peso Corporal/efeitos dos fármacos , Osso e Ossos/anormalidades , Embrião de Mamíferos/efeitos dos fármacos , Feminino , Feto/efeitos dos fármacos , Crescimento/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Tamanho do Órgão/efeitos dos fármacos , Gravidez , Coelhos , Ratos , Ratos Endogâmicos , Especificidade da Espécie , Fatores de Tempo
4.
Scand J Work Environ Health ; 7 Suppl 4: 66-75, 1981.
Artigo em Inglês | MEDLINE | ID: mdl-7330632

RESUMO

The reproductive toxicity and teratogenic potential of 19 industrial chemicals have been investigated during the past 3 a. Preliminary studies utilizing intraperitoneal treatments of rats on days 1-15 of gestation have been conducted on the following ten chemicals: allyl chloride, bisphenol A, copper naphthenate, ethylene dibromide, hexachlorobutadiene, 2-mercaptobenzothiazole, methyl styrene, naphthalene, 2-nitropropane, and 1,2,3-trichloropropane. Studies utilizing inhalation exposure of rats and rabbits on days 1-19 and 1-24, respectively, of gestation have been conducted on the following nine chemicals: butylene oxide, carbon disulfide, 2-ethoxyethanol, ethyl benzene, methyl bromide, nitrous oxide, styrene oxide, tetrachloroethylene, and trichloroethylene. In the preliminary studies, evidence of teratogenic potential was seen with allyl chloride and bisphenol A, and fetal toxicity was found in the absence of maternal toxicity with methyl styrene and 2-nitropropane. In the inhalation studies, 2-ethoxyethanol was strongly embryotoxic at the higher exposure levels employed and was teratogenic at the lower concentration.


Assuntos
Anormalidades Induzidas por Medicamentos , Teratogênicos/toxicidade , Animais , Indústria Química , Etilenoglicóis/toxicidade , Feminino , Morte Fetal/induzido quimicamente , Troca Materno-Fetal , Gravidez , Coelhos , Ratos , Ratos Endogâmicos , Reprodução/efeitos dos fármacos , Teratogênicos/administração & dosagem
5.
Teratology ; 19(2): 171-6, 1979 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-473071

RESUMO

PIP: MPA (medroxyprogeste)rone acetate) has been shown to be te)ratogenic in rabbits but not in rats or mice (Andrew and Staples 1977). Since normal steroid action appears to be mediated, in large part, through interaction with specific steroid receptors, it was postulated that the species difference in teratogenicity might be due to a difference in the interaction of MPA with target cells. A primary event in steroid-cell interaction is the binding of a steroid to intracellular receptors. Studies were initiated to measure the specific nature of MPA binding to glucocorticoid and progestin receptors in appropriate rat and rabbit target tissues. The competition of MPA with 3H-dexamethasone binding in liver cytosol (glucocorticoid receptor) and with 3H-progesterone binding in uterine cytosol (progesterone receptor) was determined. In rabbit liver cytosol, MPA was as effective at competing for specific dexamethasone binding as the natural glucocorticoids and considerably more effective than the nonspecific steroids. In rat liver cytosol MPA was only 10% as effective as the natural glucocorticoids and the competition could not be distinguished from that of nonspecific steroids. A similar species difference was not seen in uterine cytosol; MPA competed with progesterone in a similar fashion in both rat and rabbit. These data demonstrate a distinct species difference in the competitive nature of MPA for the glucocorticoid receptor but not for the progestin receptor. The results suggest that MPA, or possibly a metabolite, may be teratogenic in rabbits by binding with specific glucocorticoid receptors to inhibit or alter normal steroidal function in embryo-fetal development.^ieng


Assuntos
Anormalidades Induzidas por Medicamentos , Medroxiprogesterona/toxicidade , Receptores de Glucocorticoides/metabolismo , Receptores de Progesterona/metabolismo , Receptores de Esteroides/metabolismo , Animais , Ligação Competitiva , Citosol/metabolismo , Dexametasona/metabolismo , Feminino , Fígado/ultraestrutura , Medroxiprogesterona/metabolismo , Gravidez , Coelhos , Ratos , Especificidade da Espécie , Teratogênicos/farmacologia , Útero/ultraestrutura
6.
Teratology ; 15(1): 25-32, 1977 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-841480

RESUMO

Medroxyprogesterone acetate (MPA) was given once daily sc at 0.1-3,000 mg/kg/day for 3, 6, or 9 consecutive days during gestation days 7 to 15 to CD1 and A/J mice, and New Zealand (NZ) and Dutch Belted (DB) rabbits, and during days 8 to 16 to CD rats. Malformations attributable to MPA did not occur in fetuses of mice or rats exposed to the largest dosage tested. However, 1, 3, or 10 mg/kg on days 13 to 15 to NZ rabbits resulted in 6, 28, and 42% cleft palate, respectively. Comparable cleft palate frequencies were seen in DB offspring.


Assuntos
Anormalidades Induzidas por Medicamentos , Fissura Palatina/induzido quimicamente , Medroxiprogesterona , Animais , Peso Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Morte Fetal , Idade Gestacional , Troca Materno-Fetal , Medroxiprogesterona/toxicidade , Camundongos , Gravidez , Coelhos , Ratos
7.
Environ Health Perspect ; 18: 111-6, 1976 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1030395

RESUMO

Most studies designed for assessing teratogenic effects focus on only three of four types of final manifestations of abnormal development; namely intrauterine death, malformations, and growth retardation. Developmental toxicity evaluations generally do not include functional deficits. Current techniques are inadequate for assessing functional capability during perinatal development, and there is a need for improved measures. Thus, measurement of developmental enzyme patterns is proposed as an approach that directly evaluates acquisition of metabolic competence of fundamental organ systems. During ontogenesis most organs acquire their full complement of enzyme activities in a programmed sequence which corresponds to attainment of complete functional capability. The usual alterations in enzyme activity that characterize these patterns occur at one of three time periods, namely, late fetal, early neonatal, or late suckling. Qualitative or quantitative changes in these patterns at any time by one or more key enzymes of a tissue could be indicative of developmental toxicity. Factors are outlined relating to consideration of developmental enzyme profiles as indices of maturation capable of reflecting the action of toxic agents. This presentation: (1) reviews the current state of the art for evaluating effects on development, (2) considers the applicability of enzyme patterns for biochemical assessment of development, (3) characterizes the target tissues and those metabolic pathways and/or specific enzymes most sensitive and adaptable to practical toxicity evaluations, and (4) describes the steps being taken to validate this system. The ultimate objective of this approach is to determine whether alterations in developmental enzyme profiles will provide a technique with improved capability for assessing developmental toxicity.


Assuntos
Anormalidades Induzidas por Medicamentos/etiologia , Feto/enzimologia , Teratogênicos , Animais , Avaliação Pré-Clínica de Medicamentos , Exposição Ambiental , Feminino , Feto/efeitos dos fármacos , Métodos , Gravidez , Ratos , Projetos de Pesquisa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...